The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
For World AIDS Day, read about stigma, criminalization and more >>
  • Email Email
  • Comments Comments
  •  (1)
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Press Release

Approval of Fulyzaq (Crofelemer) to Relieve Symptoms of Diarrhea in HIV/AIDS Patients Taking Antiretroviral Therapy

January 2, 2013

On December 31, 2012, FDA approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking combination antiretroviral therapy. The recommended dose is one 125 mg delayed-release tablet taken orally two times a day, with or without food. Fulyzaq tablets should not be crushed or chewed. Tablets should be swallowed whole.

Diarrhea is experienced by many HIV/AIDS patients and is a common reason why patients discontinue or switch their antiretroviral therapies. Fulyzaq is indicated in HIV/AIDS patients whose diarrhea is not caused by an infection from a virus, bacteria, or parasite. Patients take Fulyzaq two times a day to manage watery diarrhea due to the secretion of electrolytes and water in the gastrointestinal tract.

View Full Article

  • Email Email
  • Comments Comments
  •  (1)
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Visit the FDA's website to find out more about their activities and publications.
See Also
Spotlight Series: HIV, the Gut and Digestive Issues
HIV & You: Managing Gut Symptoms
More News and Research on Diarrhea

Reader Comments:

Comment by: Samuel (London, UK.) Sat., Jan. 5, 2013 at 10:28 am EST
Wow! This could change my life. I've suffered from diarrhoea since I began treatment 7 years ago. The thing though is that I'm not "watery", just "frequent" and "mushy"! So I wonder if that would qualify me for this drug, or whether it would be better for me to take an immodium tablet every day?, could we have one of your experts discuss this, please, in a future article? Thanks.
Reply to this comment

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining: